Medical Dosimetry
Volume 35, Issue 2 , Pages 143-150 , Summer 2010

Generation of Composite Dose and Biological Effective Dose (BED) Over Multiple Treatment Modalities and Multistage Planning Using Deformable Image Registration

Received 18 November 2008 ,Accepted 4 May 2009.

References 

  1. Mock U, Kucera H, Fellner C, et al. High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: Long-term results and side effects. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:950–957
  2. Wang JZ, Li XA. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med. Phys. 2003;30:34–40
  3. Blasko J, Ragde H, Cavanagh W, et al. Long term outcomes of external beam irradiation and I-125/Pd-103 brachytherapy boost for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1996;36:198
  4. Li JG, Williams SS, Goffinet DR, et al. Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother. Oncol. 2000;56:65–71
  5. Ling CC, Burman C, Chui CS, et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:721–730
  6. Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:355–362
  7. Barker JL, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int. J. Radiat. Oncol. Biol. Phys. 2004;59:960–970
  8. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat. Res. 1985;104:S13–S19
  9. Oetzel D, Schraube P, Hensley F, et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 1995;33:455–460
  10. Guerrero T, Zhang G, Huang T-C, et al. Intrathoracic tumour motion estimation from CT imaging using the 3D optical flow method. Phys. Med. Biol. 2004;49:4147–4161
  11. Gao S, Zhang L, Wang H, et al. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med. Phys. 2006;33:3304–3312
  12. Zhang G, Huang T-C, Forster K, et al. Dose mapping: Validation in 4D dosimetry with measurements and application in radiotherapy follow-up evaluation. Comp. Meth. Prog. Biomed. 2008;90:25–37
  13. Flampouri S, Jiang SB, Sharp GC, et al. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations. Phys. Med. Biol. 2006;51:2763–2779
  14. Bookstein FL. Principal warps: Thin-plate splines and the decomposition of deformations. IEEE. Trans. Pattern. Anal. Mach. Intell. 1989;11:567–585
  15. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol. 1985;58:515–528
  16. Jani AB, Hand CM, Lujan AE, et al. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans. Med. Dosim. 2004;29:42–48
  17. Ling C. Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic model. Int. J. Radiat. Oncol. Biol. Phys. 1992;23:81–87
  18. Wahba G. Spline Models for Observational Data. Philadelphia: Society for Industrial and Applied Mathematics; 1990;
  19. Horn BKP, Schunck BG. Determining optical flow. Artif. Intell. 1981;17:185–203
  20. Jones B, Dale RG. Mathematical models of tumour and normal tissue response. Acta. Oncol. 1999;38:883–893
  21. Arai T, Kuroishi T, Saito Y, et al. Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Jpn. J. Clin. Oncol. 1994;24:199–204
  22. Dale RG. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. Br. J. Radiol. 1989;62:241–244
  23. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1999;43:1095–1101
  24. Carlson D, Stewart R, Li X, et al. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys. Med. Biol. 2004;49:4477–4491
  25. Fowler J, Chappell R, Ritter M. Is α/β for prostate tumors really low?. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:1021–1031
  26. Wang JZ, Guerrero M, Li XA. How low is the α/β ratio for prostate cancer?. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:194–203
  27. Brenner DJ. Toward optimal external-beam fractionation for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:315–316
  28. Brenner DJ. Hypofractionation for prostate cancer radiotherapy—What are the issues?. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:912–914
  29. Kampinga H, Hiemstra Y, Konings A, et al. Correlation between slowly repairable double-strand breaks and thermal radiosensitization in the human HeLa S3 cell line. Int. J. Radiat. Biol. 1997;72:293–301
  30. Brenner D, Armour E, Corry P, et al. Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): Implications for new brachytherapy protocols. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:135–138
  31. Peschel RE, Chen Z, Roberts K, et al. Long-term complications with prostate implants: Iodine-125 vs. Palladium-103. Radiat. Oncol. Invest. 1999;7:278–288
  32. NEMA. Digital Imaging and Communications in Medicine (DICOM). Rosslyn, VA: National Electrical Manufacturers Association; 2001;
  33. Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001;49:23–33

PII: S0958-3947(09)00048-X

doi: 10.1016/j.meddos.2009.05.001

Medical Dosimetry
Volume 35, Issue 2 , Pages 143-150 , Summer 2010